177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours

Clinical trial NCT04375267 · COMPLETED

Trial details

NCT number: NCT04375267
Sponsor: Vastra Gotaland Region
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Trial, Phase I Neuroendocrine Tumors Thymoma Mesothelioma

Start date: 2020-04-23
Primary completion: 2024-06-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.